DrugDashboards

good sense dual action

Acetaminophen, Ibuprofen · ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1 · Tablet, Film Coated · Oral · L Perrigo Company

NDC 00113-5300-16 · 1 BOTTLE in 1 CARTON / 144 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

19 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.1058 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Mar 2024Sep 2026$0.1058
31 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$3.17
#90 count
$9.52

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for acetaminophen and ibuprofen (oral solid) in the next 90 days

price up 19% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA214836
TE code
Approval date
Feb 28, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Acetaminophen, Ibuprofen (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Amazon.com Services LLCACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 3, 2026
L Perrigo CompanyACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 3, 2026
Walgreen CompanyACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 3, 2026
Cardinal Health 110, LLC. dba LeaderACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
CVS PharmacyACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Dolgencorp IncACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Therapeutics Inc., UsaIBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg/1Aug 26, 2026Sep 2, 2026
HyVee IncACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Kroger CompanyACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
L. Perrigo CompanyACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Publix Super Markets IncACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Retail Business Services, LLCACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Rite Aid CorporationACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Sportpharm LLCACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LLCACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
United Natural Foods, Inc. dba UNFIACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Sep 2, 2026
Meijer, Inc.ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Aug 31, 2026
Walmart Inc.ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Aug 31, 2026
Topco Associates LLCACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Aug 28, 2026
Glenmark Therapeutics Inc., UsaIBUPROFEN 250 mg/1; ACETAMINOPHEN 125 mg/1Jul 22, 2026Aug 19, 2026
Glenmark Therapeutics Inc., UsaACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "good sense dual action — NDC 00113-5300-16," retrieved September 3, 2026, https://drugdashboards.com/drug/00113530016.

Free to cite with attribution — see how the data is put together.